Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2Thoracic 1Breast 1

Conditions

Lymphoma 2Lung Neoplasms 1HER2 Positive Breast Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 909Carboplatin 786Paclitaxel 741pembrolizumab 741Bevacizumab 715Cisplatin 707Gemcitabine 621Docetaxel 583Rituximab 558Radiotherapy 546Dexamethasone 510Nivolumab 488Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 357Pemetrexed 336Oxaliplatin 335Cytarabine 334Lenalidomide 327Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 315Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Geriatric Assessment × Clear all
NCT04533451 2025-06-13

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
101 enrolled 21 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02054741 2024-04-12

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

University of Rochester

Phase NA Completed
733 enrolled 27 charts
Lymphoid

Lymphoma

NCT02107443 2024-04-12

COACH

University of Rochester

Phase NA Completed
546 enrolled 15 charts
Lymphoid

Lymphoma

NCT02673398 2023-06-18

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

City of Hope Medical Center

Phase 2 Completed
25 enrolled 18 charts
Breast

HER2 Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡